RBC Capital Markets Analysts Give Intuitive Surgical Inc. (ISRG) a $760.00 Price Target
Intuitive Surgical Inc. (NASDAQ:ISRG) has been assigned a $760.00 price target by RBC Capital Markets in a report issued on Wednesday. The firm presently has a a “hold” rating on the stock. RBC Capital Markets’ target price indicates a potential upside of 11.47% from the company’s previous close.
Other equities research analysts also recently issued research reports about the stock. Bank of America Corp. reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Wednesday, June 22nd. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $700.00 to $800.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Canaccord Genuity upped their price target on shares of Intuitive Surgical from $700.00 to $750.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Evercore ISI reissued a “buy” rating and issued a $775.00 price target (up from $750.00) on shares of Intuitive Surgical in a report on Wednesday, July 20th. Finally, Citigroup Inc. upped their price target on shares of Intuitive Surgical from $723.00 to $779.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. One analyst has rated the stock with a sell rating, six have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical currently has a consensus rating of “Buy” and a consensus target price of $715.08.
Shares of Intuitive Surgical (NASDAQ:ISRG) traded down 0.22% during midday trading on Wednesday, hitting $680.32. 155,791 shares of the stock were exchanged. Intuitive Surgical has a one year low of $492.22 and a one year high of $727.25. The stock’s 50-day moving average price is $702.77 and its 200 day moving average price is $666.57. The stock has a market cap of $26.33 billion, a P/E ratio of 36.69 and a beta of 0.72.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 18th. The company reported $6.19 earnings per share for the quarter, topping the consensus estimate of $5.13 by $1.06. The business earned $682.90 million during the quarter, compared to the consensus estimate of $650.49 million. Intuitive Surgical had a net margin of 27.51% and a return on equity of 15.02%. The company’s quarterly revenue was up 15.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.24 earnings per share. On average, analysts anticipate that Intuitive Surgical will post $21.30 earnings per share for the current year.
In other news, CEO Gary S. Guthart sold 13,400 shares of the stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $698.00, for a total value of $9,353,200.00. Following the completion of the sale, the chief executive officer now directly owns 78,780 shares of the company’s stock, valued at $54,988,440. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $688.33, for a total value of $2,064,990.00. Following the completion of the transaction, the senior vice president now owns 2,331 shares of the company’s stock, valued at $1,604,497.23. The disclosure for this sale can be found here. 3.10% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Acropolis Investment Management LLC purchased a new position in shares of Intuitive Surgical during the third quarter worth approximately $109,000. Global X Management Co. LLC purchased a new position in shares of Intuitive Surgical during the second quarter worth approximately $118,000. Bartlett & Co. LLC raised its position in shares of Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares during the last quarter. Glenmede Trust Co. NA raised its position in shares of Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares during the last quarter. Finally, Bessemer Group Inc. raised its position in shares of Intuitive Surgical by 59.0% in the first quarter. Bessemer Group Inc. now owns 318 shares of the company’s stock worth $191,000 after buying an additional 118 shares during the last quarter. Institutional investors and hedge funds own 92.03% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.